Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana van den Berg

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|March 26, 2025
The Changing Role of Allogeneic Stem Cell Transplantation in Adult B-ALL in the Era of CAR T Cell TherapyJana van den Berg, Claudia Meloni, Jörg Halter, et al.
Hamostaseologie|February 19, 2025
Basic Concepts and Indications of CAR T CellsJana van den Berg, Heinz Läubli, Nina Khanna, et al.
Blood Advances|September 22, 2021
Daratumumab for immune thrombotic thrombocytopenic purpuraJana van den Berg, Johanna A Kremer Hovinga, Claudia Pfleger, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-upRoman Schimmer, Jana van den Berg, Marissa Schraner, et al.
Bone Marrow Transplantation|August 13, 2024
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantationMarie Janscak, Anne Stelmes, Jana van den Berg, et al.
Anticancer Research|August 30, 2022
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case SeriesVera Dalla Via, Anne Stelmes, Mike Recher, et al.
Research and Practice in Thrombosis and Haemostasis|June 19, 2023
Von Willebrand factor and the thrombophilia of severe COVID-19: <i>in situ</i> evidence from autopsiesJana van den Berg, Jasmin D Haslbauer, Anna K Stalder, et al.
Developmental Cell|June 19, 2012
Identification and regulation of a molecular module for bleb-based cell motilityMehdi Goudarzi, Torsten U Banisch, Mehrpouya B Mobin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|March 26, 2025
The Changing Role of Allogeneic Stem Cell Transplantation in Adult B-ALL in the Era of CAR T Cell TherapyJana van den Berg, Claudia Meloni, Jörg Halter, et al.
Hamostaseologie|February 19, 2025
Basic Concepts and Indications of CAR T CellsJana van den Berg, Heinz Läubli, Nina Khanna, et al.
Blood Advances|September 22, 2021
Daratumumab for immune thrombotic thrombocytopenic purpuraJana van den Berg, Johanna A Kremer Hovinga, Claudia Pfleger, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-upRoman Schimmer, Jana van den Berg, Marissa Schraner, et al.
Bone Marrow Transplantation|August 13, 2024
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantationMarie Janscak, Anne Stelmes, Jana van den Berg, et al.
Anticancer Research|August 30, 2022
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case SeriesVera Dalla Via, Anne Stelmes, Mike Recher, et al.
Research and Practice in Thrombosis and Haemostasis|June 19, 2023
Von Willebrand factor and the thrombophilia of severe COVID-19: <i>in situ</i> evidence from autopsiesJana van den Berg, Jasmin D Haslbauer, Anna K Stalder, et al.
Developmental Cell|June 19, 2012
Identification and regulation of a molecular module for bleb-based cell motilityMehdi Goudarzi, Torsten U Banisch, Mehrpouya B Mobin, et al.
Pageof 1